MedicineEnvironmental Science

M. Skwarski, E. Bowler, Joseph D. Wilson, G. Higgins, E. Hammond

2020Cancer Drug Discovery and Development

DOI: 10.1007/978-3-030-49701-9_11

tlooto Summary

Tumor hypoxia significantly impacts tumor radiosensitivity and subsequently leads to poor clinical outcomes in patients treated with radiation therapy, and the lack of robust, widely available, and adequately validated biomarkers for assessing tumor Hypoxia in patients is a major limitation.

Abstract

Abstract is not available.

Citation format

SKWARSKI, M., et al. Targeting tumor hypoxia. Cancer Drug Discovery and Development, 2020.